in Belgium HSPA report 1 PMeeus MD MPHMHA Pascalmeeus inamifgovbe OECD 23102014 Introduction Efficiency indicators within Be HSPA Other in efficiency indicators within Be HSPA ID: 616067
Download Presentation The PPT/PDF document "How do we measure Efficiency" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
How do we measure Efficiency in Belgium HSPA report
1
P.Meeus
MD, MPH,MHA,
Pascal.meeus
@
inami.fgov.be
OECD 23/10/2014Slide2
Introduction Efficiency indicators within Be HSPAOther (in) efficiency indicators within Be HSPA ?
Discussion
2Slide3
Introduction Efficiency indicators
within Be HSPAOther (in)
efficiency
indicators
within Be HSPA ?Discussion
3Slide4
Health
system objectives
Equitable system ?
Efficiency
?
Slide5
Conceptual model (be)
5
Quality = appropriateness, safety, efficacy, continuity, patient
centerdnessSlide6
Dimensions 6Slide7
Criteria for indicators
7
Base
for
international
benchmark: EU-15Slide8
Introduction Efficiency indicators
within Be HSPA
Other
(in)
efficiency
indicators within Be HSPA
Discussion
8Slide9
HSPA Belgium: list of indicators: Efficiency 9Slide10
HSPA Belgium: list of indicators: Efficiency
10Slide11
PRICE PER CASE 2012: surgical conditions (ONE DAY /CLASSIC ) (PPP hospital OECD)11
One day is more efficient than classic hospitalisation
.
Day surgery is usually cheaper in Belgium, (-20%--40%)
…. Except for cataract surgery (+25%- 40%) Slide12
HSPA Belgium: list of indicators: Efficiency 12Slide13
ALOS 2012: GYNECOLOGY13Slide14
HSPA Belgium: list of indicators: Efficiency
14Slide15
15
Low cost medicines % low cost (DDD/ inh /year )Slide16
16
Low cost medicines
targets and results (Belgium 2013)
Low
cost
medicines
by
medical
specialities
% of
target
(2013) Slide17
17Low cost medicines % low cost ( DDD) versus Expenses (EUR)
expenses
Slide18
18
Low cost medicines: DDD /inh evolution
Quality
expenses
Slide19
HSPA Belgium: list of indicators: Efficiency
19Slide20
Breast
cancer screening
(50-69
)
20
MISUSESlide21
Introduction Efficiency indicators within
Be HSPAOther
(in)
efficiency
indicators within Be HSPA
Discussion
21Slide22
HSPA Belgium: list of indicators: Efficiency
22Slide23
HSPA Belgium: list of indicators: What about efficiency in other dimensions ?
23Slide24
Bed days / inhabitant24
Source: OECD Health data 2012
International comparaison: Nb acute
bed
days
high in B.
=
based
on RCM/MKG, (
exclude
one
day
+ RPM / MPG)
OVERUSE:
Inefficiency
+
Sustainability
issues Slide25
Breast cancer screening outside target group (40-49) & (70-80)
Mammographies réalisées chez les femmes de moins de 50 ans ou de plus de 72 ans
Figure 9.
Figure 10.
OVERDIAGNOSIS :
(In)
Appropriateness
&
safety
issues
=
Waste
->
inefficiencySlide26
Knee Arthroscopy26
Unexplained
geographical
variations
in
diagnosis
consumption
UNDERUSE , OVER USE ,
MISUSE ? ->
inefficiency
Slide27
Introduction Efficiency indicators within
Be HSPAOther (in)
efficiency
indicators
within Be HSPADiscussion
27Slide28
Discussion (1/3)28Slide29
Discussion (2/3) 29Slide30
30